Immigrants Are a Boon to the U.S. Economy
President Donald Trump is deporting immigrants—11,000 last month. Some people are unhappy about that. Last week a judge ...
Antelope Valley Press9 小时Opinion
FDA can save lives by keeping copycat drugs off the market
For decades, the United States has led the world in pharmaceutical innovation — developing drugs that combat cancer, heart ...
Creators Syndicate on MSN1 天Opinion
The Good, the Bad, the Undocumented
President Donald Trump is deporting immigrants — 11,000 last month. Some people are unhappy about that. Updated: Wed Mar 19, ...
The FDA can save lives by keeping copycat drugs off the market
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Opinion
Minot Daily News13 小时Opinion
There’s good people in every culture
President Donald Trump is deporting immigrants — 11,000 last month. Some people are unhappy about that. Last week a judge ordered a stop to Trump’s removal of Venezuelan nationals. (Deportation ...
A hard pill to swallow: US call to impose tariffs on Australian pharmaceuticals
An American pharmaceutical lobby group has urged US president Donald Trump to impose tariffs on Australia-made drugs, citing ...
BizPac Review1 天
Stephen Moore: The FDA can save lives by keeping copycat drugs off the market
The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold ...
The New York Sun1 天Opinion
Federal Drug Regulators Threaten America’s Innovative Pharmaceutical Industry
Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.
Prescott eNews1 天Opinion
Opinion: The Good, the Bad, the Undocumented – John Stossel
“Yes,” Brook answers, “But if we are confident in the ideas that we have, individual rights … capitalism and liberty, we ...
Townhall2 天
The FDA Can Save Lives by Keeping Copycat Drugs Off the Market
They generated nearly $5 billion in revenues in 2023. Compounders freeload off the high R&D costs and slow approval times associated with developing new drugs. Instead, they modify patented ...